ST. LOUIS, MISSOURI — Amptify has announced that Chris Cardinal, President and Chief Operating Officer of Amptify, has been appointed Chief Executive Officer, effective immediately, succeeding Nancy Tye-Murray, PhD.
Dr. Tye-Murray remains in her position as Chair of the Board and assumes the position of Chief Scientific Officer.
Cardinal joined Amptify as President and COO in early 2019 on the heels of the successful 2018 acquisition of his previous company, Welltodo, which developed the world’s preeminent digital-therapeutic (DTx) for migraine. As Amptify’s COO, he has expanded the company’s offerings to include a platform catering to audiologists and a DTx for hearing loss. He also added a Clinical Research Organization division, Amptify Labs, which has conducted several usability and clinical trials for both the government and private industry.
“Appointing Chris as CEO was the obvious next step in our company’s evolution. Historically, the hearing healthcare industry has been slow-to-change and content to conduct business-as-usual. Chris’s thinking is futuristic and visionary. He’s has helped changed my colleagues’ conception of what is possible if we embrace technology and embrace a more entrepreneurial approach. What I find most gratifying is that by so doing, members of my profession are rethinking what comprises the gold standard of audiological care, especially when it comes to providing aural rehabilitation and promoting cognitive health. Business-wise, I’m amazed by how quickly he has found product-market fit to put Amptify on the radar and gotten us off the runway and into the air.”
–Nancy Tye-Murray, PhD
**For more information about the appointment, read the company announcement here.
Readers may be interested to watch last year’s interview with Nancy Tye-Murray and Chris Cardinal regarding digital therapeutics in hearing healthcare:
About Amptify
Amptify was founded in 2015 by a world-renowned aural rehabilitation research team as a University spin-off from the Audiovisual Speech Perception Laboratory at the Washington University in St. Louis School of Medicine. Funded by the National Institute of Health (NIH), research in this university lab began to develop products for individuals with hearing loss that improve communication along with their social, psychological, and physical sense of well-being. Amptify represents the culmination of decades of NIH-sponsored research.
Source: Amptify
